GeoVax Labs, Inc. (GOVX) › Operating Cash FlowGeoVax Labs, Inc. (GOVX) — Operating Cash FlowAnnual figures by period end, from SEC filings.2009-12-31: -$1.43M2010-12-31: -$2.44M2011-12-31: -$303.6K2012-12-31: -$2.44M2013-12-31: -$1.69M2014-12-31: -$2.25M2015-12-31: -$2.71M2016-12-31: -$1.95M2017-12-31: -$1.69M2018-12-31: -$1.54M2019-12-31: -$1.40M2020-12-31: -$2.75M2021-12-31: -$11.20M2022-12-31: -$19.03M2023-12-31: -$25.17M2024-12-31: -$24.68M2025-12-31: -$21.47M-$21.47M2009-12-31Operating Cash Flow (USD)2025-12-31Period endedOperating Cash FlowChange YoYSource filing2025-12-31-$21.47M—2026-04-15From 2025-01-012024-12-31-$24.68M—2026-04-15From 2024-01-012023-12-31-$25.17M—2025-03-27From 2023-01-012022-12-31-$19.03M—2024-02-29From 2022-01-012021-12-31-$11.20M—2023-03-23From 2021-01-012020-12-31-$2.75M—2022-03-09From 2020-01-012019-12-31-$1.40M—2021-03-23From 2019-01-012018-12-31-$1.54M—2020-03-24From 2018-01-012017-12-31-$1.69M—2019-03-26From 2017-01-012016-12-31-$1.95M—2019-03-26From 2016-01-012015-12-31-$2.71M—2018-03-23From 2015-01-012014-12-31-$2.25M—2017-03-24From 2014-01-012013-12-31-$1.69M—2016-03-16From 2013-01-012012-12-31-$2.44M—2015-03-20From 2012-01-012011-12-31-$303.6K—2014-03-14From 2011-01-012010-12-31-$2.44M—2013-03-18From 2010-01-012009-12-31-$1.43M—2012-03-30From 2009-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)